Dangerous side effects, undisclosed risks, contaminated medications — pharmaceutical companies are required by law to warn you of known dangers. When they hide the truth to protect profits, people get hurt. We fight back.
Yes. A recall is not required. If the drug's manufacturer knew of serious risks and failed to warn doctors and patients, that's a failure-to-warn claim. Many of the largest pharmaceutical verdicts involved drugs that were never formally recalled.
Multidistrict litigation consolidates thousands of similar drug cases before a single federal judge for pre-trial proceedings. Joining an MDL can be strategic — it pools resources, creates leverage for global settlements, and avoids years of individual litigation. We evaluate whether MDL or individual litigation is better for your specific situation.
Not necessarily. Manufacturers have a duty to update labels as new risks emerge. If they knew about a serious risk and delayed updating the label, or if the label language was buried or misleading, you still have a claim. This is where expert analysis of the label history is critical.
New York's discovery rule starts the clock when you knew or reasonably should have known the drug caused your injury — not when you took it. If your injury was recently diagnosed or recently linked to the medication, you may still be within the statute of limitations. Call us immediately to evaluate your timeline.
It depends on the severity of your injury, the drug manufacturer's knowledge and conduct, and whether there is an existing MDL settlement fund. Cases involving serious long-term injuries — cancer, organ failure, birth defects — often result in six or seven-figure settlements. We evaluate every case individually.
Free consultation. No fee unless we win. Evidence disappears fast — don't wait.